Skip to content

Diclofenac Phonophoresis Versus High Power Pain Threshold Ultrasound on Patients With Neck Pain

Diclofenac Phonophoresis Versus High Power Pain Threshold Ultrasound in Patients With Mechanical Non-specific Neck Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05434039
Acronym
NP
Enrollment
60
Registered
2022-06-27
Start date
2022-07-30
Completion date
2022-09-01
Last updated
2022-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Keywords

phonophoresis, high power pain threshold ultrasound, neck pain

Brief summary

the aim of this study is to investigate the effect of diclofenac phonophoresis versus high power pain threshold ultrasound in patients with mechanical non-specific neck pain

Detailed description

Neck pain can be a long-lasting condition, Between half and three quarters of patients with neck pain will experience recurrence within 1-5 years. Costs for the society due to neck pain are consequently high. Neck pain (NP) is one of the common musculoskeletal problems. NP can be caused by the stress over the musculoskeletal system due to postural disorders and may also be associated with other causes such as intervertebral disc herniation, nerve compression, or fracture. Musculoskeletal pain due to trigger points is one of the most prevalent reasons for patients to seek treatment. The aim of physical therapy treatment in patient with myofascial pain syndrome is to reduce the pain and restore normal function. Most physical therapy treatments for MPS are targeted to the deactivation of MTrPs. Physical therapy techniques include manual therapies; such as ischemic compression, spray and stretch, strain and counter strain, muscle energy techniques, trigger point pressure release, transverse friction massage; needling therapies, and other techniques such as thermotherapy, ultrasound therapy , phonophoresis and laser therapy.Due to the semi-solid properties, a special method is needed for transdermal permeation of lidocaine. Therefore, many studies have focused on enhancing the level of transdermal permeation by either changing the physiochemical properties of lidocaine or using physical modalities In particular, there has been considerable interest in transdermal permeation using various methods based on the idea that the amount and depth of transdermal permeation can be increased using various physical modalities. patients with mechanical neck pain will be allocated randomly into three equal groups; group A will receive phonophoresis and traditional therapy, group B will receive high power pain thresholdand traditional therapy and group C will receive traditional therapy

Interventions

OTHERdiclofenac phonophoresis

the patients will be in comfortable position and apply diclofenac phonophoresis on upper trapezius and suboccipital muscle by ultrasound device. diclofenac gel was applied circularly with a thickness of 2-3 mm. Then ultrasound with was applied with 1 MHz frequency and 1.5 Wt/cm2 power over the trigger points on the trapezius and suboccipital muscle, for 10 min.

the patients will be in comfortable position and The frequency was set to 1 MHz, and the intensity will be increased from 0.5 to 2 until the patient reported an unpleasant sensation. The probe was held there for 4 s; then, the intensity was reduced by 50%, and the probe will be moved over and around the trigger point. This process is done several times for three minutes

OTHERconventional therapy

the patient will receive an active range of motion exercise, stretching and strengthening of all cervical muscles

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

random generator

Intervention model description

diclofenac phonophoresis and high power pain threshold

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

1. diagnosed as non-specific neck pain with upper trapezius and suboccipital muscles active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern 2. body mass index from 18 to 25 kg/m2 3. their ages from 18-30

Exclusion criteria

1. if they had trigger point injections within the past 6 months 2. history of neck or upper back surgery, trauma or fracture 3. history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities 4. cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Design outcomes

Primary

MeasureTime frameDescription
pain intensityup to four weeksThe scale that will be used is visual analogue scale ;each subject will be instructed to put point on line from no pain to tolerable pain

Secondary

MeasureTime frameDescription
cervical range of motionup to four weeksrange of cervical will be measured by CROM device
pressure pain thresholdup to four weekspressure pain threshold will be measured by commander algometer
neck disabilityup to four weeksneck disability will be measured by Arabic neck disability index

Contacts

Primary Contactal shaymaa sh abd el azeim, lecturer
shimaashaaban30@yahoo.com01033771553
Backup Contactal shaymaa abd el azeim, lecturer
shimaashaaban30@yahoo.com01033771553

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026